Maglev-fabricated long and biodegradable stent for interventional treatment of peripheral vessels

Author:

Ding Jiandong1ORCID,Zhang Wanqian2,Gao Xian3,Zhang Hongjie1,Sun Guoyi4,Zhang Gui5,Li Xin6,Qi Haiping7,Guo Jingzhen8,Qin Li7,Shi Daokun8,Shi Xiaoli3,Li Haifeng7,Zhang D.Y.9ORCID,Guo Wei4ORCID

Affiliation:

1. Fudan University

2. Lifetech Scientific (Shenzhen) Co. Ltd., Fudan University

3. National and Local Joint Engineering Laboratory of Interventional Medical Biotechnology and System, Biotyx Medical (Shenzhen) Co., Ltd, Lifetech Scientific (Shenzhen) Co. Ltd.

4. Chinese PLA General Hospital

5. Lifetech Scientific (Shenzhen) Co.

6. 17110440006@fudan.edu.cn

7. Lifetech Scientific (Shenzhen) Co. Ltd.

8. State Key Laboratory of Molecular Engineering of Polymers, Department of Macromolecular Science, Fudan University

9. Lifetech Scientific (Shenzhen) Co Ltd

Abstract

Abstract While chronic limb-threatening ischemia is a serious peripheral artery disease, the lack of an appropriate stent significantly limits the potential of interventional treatment. In spite of much progress in coronary stents, little is towards peripheral stents, which are expected to be long and biodegradable and thus require more breakthroughs in core techniques. Herein, we develop a long & biodegradable stent (LBS) with a length of up to 118 mm based on a metal-polymer composite material. Nitriding treated iron with elevated mechanical performance was applied as the skeleton of the stent, and a polylactide coating was used to accelerate iron degradation. To achieve a well-prepared homogeneous coating on a long stent during ultrasonic spraying, a magnetic levitation (Maglev) was employed. In vivo degradation of the LBS was investigated in rabbit abdominal aorta/iliac arteries, and preclinical safety and efficacy were evaluated in canine infrapopliteal arteries. First-in-man implantation of LBS was carried out in the below-the-knee artery, and the 6–13 months follow-ups demonstrated the feasibility of the first LBS.

Publisher

Research Square Platform LLC

Reference48 articles.

1. Critical limb ischemia: current challenges and future prospects;Uccioli L;Vasc Health Risk Manag,2018

2. The GVG Writing Group, Global vascular guidelines on the management of chronic limb-threatening ischemia;Conte MS;Eur J Vasc Endovasc Surg,2019

3. AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: A report of the American college of cardiology/American heart association task force on clinical practice guidelines;Gerhard-Herman MD;J Am Coll Cardiol,2017

4. Comparative performance analysis of interventional devices for the treatment of ischemic disease in below-the-knee lesions: a systematic review and meta-analysis;Matsuoka EK;Circ Cardiovasc Interv,2022

5. Morel, M. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease;Serruys PW;New Eng J Med,1994

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3